Impact of structured medication reviews on prescribing in English primary care: a retrospective observational cohort study

Share:

Background Structured medication reviews (SMRs) were introduced in 2020 to address polypharmacy in patients most at risk of medicines-related harm.

Aim To evaluate the impact of SMRs on prescribing in primary care.

Design and setting Retrospective observational cohort study of electronic health records from patients aged ≥65 years, prescribed ≥1 medications, and fulfilling the specific eligibility criteria for an SMR, registered at practices contributing data to the Oxford Clinical Informatics Digital Hub, between 1 April 2020 and 30 September 2022.

Method The association between SMRs and prescription changes was examined by matching individuals who received an SMR to individuals who did not receive an SMR, according to age, sex, and primary care practice, using cumulative density sampling. Analyses were undertaken using adjusted logistic regression.

Results Of 635 698 eligible patients, 82 285 (12.9%, 95% confidence interval [CI] = 12.9 to 13.0) received ≥1 SMR during the study observation period. In those prescribed potentially inappropriate drug combinations prior to an SMR, between 12.5% and 40.0% were corrected up to 3 months later. In matched analyses, SMRs were most strongly associated with an increase in new prescriptions of angiotensin-converting enzyme inhibitors (adjusted odds ratio [aOR] 1.56, 95% CI = 1.35 to 1.81), statins (aOR 1.78, 95% CI = 1.57 to 2.02), and antidepressants (aOR 1.45, 95% CI = 1.28 to 1.63). SMRs were also most strongly associated with stopping these drug classes in those previously prescribed treatment.

Conclusion SMRs were associated with starting new medications and stopping existing prescriptions compared with usual care. Further work is needed to understand if these changes improved patient outcomes.

References: Sheppard J, Bateman P, Wright-Drakesmith C, Clark CE, Barnes RK, Clegg AP, Ford GA, Gadhia S, Hinton W, Hobbs FDR, Jawad S, Khunti K, Lip GYH, de Lusignan S, Mant J, McCahon D, Meza-Torres B, Payne RA, Perera R, Reidy C, Seeley A, Seidu S, Tucker S, Van Der Veen R, Williams M, McManus R. Impact of structured medication reviews on prescribing in English Primary Care. British Journal of General Practice 2026; BJGP.2025.0617.

Details:

Author(s):

James P Sheppard, Paul A Bateman, Cynthia Wright-Drakesmith, Christopher Elles Clark, Rebecca K Barnes, Andrew Paul Clegg, Gary A Ford, Seema Gadhia, William Hinton, FD Richard Hobbs, Sundus Jawad, Kamlesh Khunti, Gregory YH Lip, Simon de Lusignan, Jonathan Mant, Deborah McCahon, Bernardo Meza-Torres, Rupert A Payne, Rafael Perera-Salazar, Claire Reidy, Anna Seeley, Samuel Seidu, Katherine Tucker, Rik van der Veen, Marney Williams, Richard J McManus

Related Publications

What are the Priorities for Research of Older People Living in Care Homes? A Systematic Review and Content Analysis of Studies Reporting Care Home Residents’ Priorities and Unmet Needs

Group Poetry and Quilt-Making –Creative Public Involvement Approaches to Contentious Concepts in Frailty Research

Integrating frailty into decision-making for disease-modifying therapies in Alzheimer’s disease: a proposed expert-opinion based approach

ARC
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.